NQO2 Cancer Research Results
NQO2, N-ribosyldihydronicotinamide:quinone reductase 2: Click to Expand ⟱
| Source: |
| Type: |
Curcumol exhibits synergistic lethal effects with TRAIL on cancer cell by directly targeting quinone oxidoreductase 2 (NQO2) to induce reactive oxygen species, triggering ER stress‐C/EBP homologous protein (CHOP)‐death receptor 5 (DR5) signaling to combat TRAIL‐resistant cancer.
|
Scientific Papers found: Click to Expand⟱
NQO1↑, P53↑, NQO2↑, chemoPv↑, TumCP↓, AR↓,
*AntiDiabetic↑, *AntiAge↑, *toxicity⇅, *CRM↑, *Strength↑, *LDL↓, *AMPK↑, *TAC↑, *ROS↓, *Inflam↓, Risk↓, *cardioP↑, *ALAT↓, *NRF2↑, *SOD2↑, *TrxR1↑, *NQO1↑, *NQO2↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
NQO1↑, 1,
Protein Folding & ER Stress ⓘ
NQO2↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Migration ⓘ
TumCP↓, 1,
Hormonal & Nuclear Receptors ⓘ
AR↓, 1,
Clinical Biomarkers ⓘ
AR↓, 1,
Functional Outcomes ⓘ
chemoPv↑, 1, Risk↓, 1,
Total Targets: 8
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
NQO1↑, 1, NRF2↑, 1, ROS↓, 1, SOD2↑, 1, TAC↑, 1, TrxR1↑, 1,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1, AMPK↑, 1, CRM↑, 1, LDL↓, 1,
Protein Folding & ER Stress ⓘ
NQO2↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1,
Functional Outcomes ⓘ
AntiAge↑, 1, AntiDiabetic↑, 1, cardioP↑, 1, Strength↑, 1, toxicity⇅, 1,
Total Targets: 18
Scientific Paper Hit Count for: NQO2, N-ribosyldihydronicotinamide:quinone reductase 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:435 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page